Intragastric Balloon Market Size & Share 2026-2035

Intragastric Balloon Market Size

The global intragastric balloon market was valued at USD 77.5 million in 2025. The market is expected to reach from USD 87.8 million in 2026 to USD 312.9 million in 2035, growing at a CAGR of 15.2% during the forecast period, according to the latest report published by Global Market Insights Inc.

Intragastric balloon is a non-surgical weight-loss device placed in the stomach to reduce its capacity, helping patients feel fuller with less food. It is typically used for obese individuals who have not been successful with diet and exercise alone. The balloon is inserted via endoscopy or a pill and removed after a few months.

The major players in the global intragastric balloon market are Boston Scientific, Allurion, Helioscopie, ReShape Lifesciences, and SPATZ. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.

The market has increased from USD 51.7 million in 2022 and reached to USD 68.5 million in 2024, with a historic growth rate of 15%. The market growth was driven by the rising prevalence of obesity, increasing preference for minimally invasive weight-loss procedures, and growing awareness regarding bariatric endoscopic treatments.

Moreover, the increasing prevalence of obesity worldwide is creating a higher demand for weight-loss solutions. For instance, according to the World Health Organization (WHO) data from 2023, more than 1 billion people globally are obese, including 160 million children.

The Centers for Disease Control and Prevention (CDC) reported in 2022 that 42.4% of U.S. adults were obese, with an estimated annual medical cost of USD 173 billion. These rising obesity rates are prompting individuals to pursue treatments like intragastric balloons to control their weight and minimize health risks associated with obesity, including diabetes and cardiovascular disease.

Furthermore, continuous innovations in balloon materials, adjustable balloon systems, and swallowable capsule-based balloons are improving the safety and effectiveness of the treatment. Advanced designs reduce procedure complexity and improve patient comfort. These technological improvements are encouraging physicians and clinics to offer intragastric balloon treatments more widely.

Intragastric Balloon Market Trends

The market is witnessing significant growth driven by increasing adoption of swallowable balloon technologies, integration of digital health and remote patient monitoring, and expansion of specialized bariatric and weight-management clinics, among other factors are boosting the industry growth.

• A major trend in the intragastric balloon market is the development of swallowable balloon systems that do not require endoscopy or anesthesia for placement. These capsule-based balloons simplify the procedure and improve patient convenience. Such innovations reduce hospital stay and procedure complexity, making weight-loss therapy accessible to a broader patient population. The growing acceptance of these minimally invasive technologies is accelerating market adoption.
• Manufacturers are increasingly integrating digital health platforms, mobile applications, and virtual care programs with intragastric balloon therapy. These platforms enable clinicians to monitor patient progress, dietary habits, and physical activity remotely. Advanced solutions even use AI-driven coaching systems to support behavioral changes and improve treatment outcomes. This trend is shifting the market toward comprehensive obesity management rather than device-only treatment.
• Further, medical tourism is emerging as an important trend in the market. Patients from high-cost healthcare regions are increasingly travelling to countries offering affordable weight-loss procedures. Emerging economies with advanced bariatric facilities are attracting international patients seeking cost-effective obesity treatment options. This cross-border demand is expanding the global patient pool and supporting market growth.

Intragastric Balloon Market Analysis

Based on product, the intragastric balloon market is segmented into single intragastric balloon, dual intragastric balloon, and triple intragastric balloon. The single intragastric segment has asserted its dominance in the market by securing a significant market share of 60.2% in 2025 owing to its widespread clinical adoption, simpler placement and removal procedures, lower complication rates, and the availability of well-established products such as single saline-filled balloon systems. The segment is expected to exceed USD 181.6 million by 2035, growing at a CAGR of 14.7% during the forecast period.

On the other hand, the dual intragastric balloon segment is expected to grow with a CAGR of 15.9%. The growth of this segment is driven by its enhanced safety profile, improved space occupancy in the stomach for better satiety, and reduced risk of balloon migration due to the presence of two connected balloons.

• The single intragastric balloon segment continues to dominate the market, as these balloons are simpler to deploy compared to dual-balloon devices. They involve a straightforward insertion process and can be placed more quickly, which is appealing to both healthcare providers and patients. This simplicity reduces procedure time and minimizes the risk of complications, contributing to their widespread adoption.
• Furthermore, single balloons are generally less expensive than dual-balloon systems, making them an attractive option for patients seeking a more affordable weight-loss solution. Their lower cost also enhances market accessibility, particularly in regions with price-sensitive populations or limited insurance coverage for such treatments.
• The triple intragastric balloon segment held a revenue of USD 7.6 million in 2025, with projections indicating a steady expansion at a CAGR of 15.3% from 2026 to 2035. The growth of the segment is driven by their enhanced gastric space occupancy, which can provide stronger satiety signals and potentially improve weight-loss outcomes. Additionally, increasing research into multi-balloon configurations for better treatment effectiveness and patient-specific therapy approaches is supporting interest in this segment.

Based on filling material, the market is classified into saline-filled balloon and gas-filled balloon. The saline-filled balloon segment accounted for USD 54.6 million market revenue in 2025 and is anticipated to grow at a CAGR of 14.8% between the 2026 to 2035 period.

• Saline-filled balloons are known for their strong safety profile. The saline solution inside the balloon ensures that if the balloon leaks or bursts, it causes minimal harm, as the body can absorb the saline without significant adverse effects. This safety feature makes saline-filled balloons an appealing option for patients and healthcare providers concerned about complications.
• Additionally, it offers a more controlled and stable inflation process compared to air-filled balloons, which are more prone to deflation or leakage. This reduces the risk of balloon-related issues and enhances the long-term effectiveness of the treatment, making it a reliable choice for weight loss. These advantages are expected to drive growth in this segment of the market.
• The gas-filled balloon segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 15.9% over the forecast period. The segmental growth is supported by their lighter weight compared to saline-filled balloons, which improves patient comfort and reduces symptoms such as nausea and abdominal discomfort. Additionally, shorter placement procedures and easier removal through minimally invasive endoscopy are encouraging their adoption among clinicians and patients.

Based on administration, the intragastric balloon market is classified into endoscopy and pill form. The endoscopy segment dominated the market in 2025 with a market share of 74.3%.

• Endoscopy is a minimally invasive technique, which significantly reduces the risks associated with traditional surgery. It involves inserting the balloon into the stomach through the mouth using an endoscope, without the need for incisions or stitches. This makes it a highly appealing option for patients seeking less invasive alternatives to weight loss surgery, driving its adoption in the market.
• Further, the endoscopic procedure for inserting the intragastric balloon typically requires only local anesthesia or mild sedation, rather than general anesthesia. This results in reduced discomfort and faster recovery for patients. The less invasive nature of endoscopy enhances patient satisfaction and increases the likelihood of adoption. This is anticipated to boost the segmental growth in the market.
• The pill form segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 16.1% over the forecast period. The segmental growth is driven by the elimination of endoscopy, anesthesia, and surgical intervention, making the treatment more convenient and less intimidating for patients. In addition, increasing adoption in outpatient weight-management programs and wellness clinics is supporting demand for this non-invasive approach.

Based on end use, the intragastric balloon market is classified into hospitals, ambulatory surgical centers, specialty clinics, and other end users. The hospitals segment dominated the market with a revenue share of 43% in 2025 and is expected to reach USD 131 million within the forecast period.

• The increasing global obesity rates have prompted hospitals to provide effective weight management solutions. Intragastric balloon treatments offer a non-surgical approach to address obesity and related health conditions, including diabetes and heart disease. This has led hospitals to incorporate these treatments into their medical services.
• Moreover, offering intragastric balloon treatments provides hospitals with a new revenue stream. As demand for weight-loss treatments rises, hospitals can capitalize on this trend by incorporating the procedure into their service offerings. Additionally, it provides hospitals with the opportunity to enhance their bariatric services without the need for complex surgical infrastructure.
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 15.4% over the forecast period. The growth of the segment is driven by the increasing shift toward outpatient bariatric procedures that offer faster patient turnaround and operational efficiency. Additionally, shorter waiting times and streamlined procedural workflows in ASCs are encouraging healthcare providers to perform intragastric balloon placements in these settings.
• The specialty clinics segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 15.8% over the forecast period. The segment is driven by the increasing number of dedicated weight-management and bariatric clinics offering personalized obesity treatment programs. Additionally, integrated services such as nutritional counseling, lifestyle coaching, and follow-up care in these clinics are encouraging higher patient preference for intragastric balloon procedures.

North America Intragastric Balloon Market

North America dominated the global intragastric balloon industry with the highest market share of 38.9% in 2025.

• The U.S. market was valued at USD 18.9 million and USD 21.8 million in 2022 and 2023, respectively. The market size reached USD 28.4 million in 2025, growing from USD 25.1 million in 2024, and is anticipated to grow at a CAGR of 15.1% from 2026 to 2035.
• North America, particularly the U.S., has one of the highest obesity prevalence rates globally. Sedentary lifestyles, high-calorie diets, and increasing consumption of processed foods have significantly increased the obese population. As obesity is strongly linked with diabetes, cardiovascular diseases, and metabolic syndrome, healthcare providers are increasingly recommending early weight-management interventions. Intragastric balloons are widely considered an effective non-surgical solution for individuals who do not qualify for bariatric surgery but require medical weight reduction.
• The region benefits from a highly developed healthcare infrastructure, with a large number of specialized bariatric surgery centers and gastroenterology clinics. Hospitals and outpatient endoscopy centers are well-equipped to perform intragastric balloon procedures. The availability of skilled gastroenterologists and bariatric specialists further supports procedural adoption. Additionally, structured weight management programs offered by hospitals help integrate balloon therapy with lifestyle and nutritional counseling.

Europe Intragastric Balloon Market

Europe market accounted for USD 22.6 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Several European governments are implementing public health initiatives to address rising obesity levels across the region. Policies promoting healthier diets, physical activity, and early medical intervention are encouraging individuals to seek professional weight management treatments. Intragastric balloon therapy is gaining attention as a medically supervised, non-surgical solution. The inclusion of obesity management in healthcare strategies across countries such as the UK, Germany, and France is supporting market growth.
• The region has seen a growing number of private bariatric clinics and aesthetic medical centers offering weight management treatments. Many of these clinics provide personalized treatment programs that include intragastric balloon placement, dietary counseling, and long-term follow-up care. The increasing availability of specialized centers has improved accessibility for patients seeking non-surgical weight-loss options. This trend is particularly evident in Western Europe.

Asia Pacific Intragastric Balloon Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 16.1% during the analysis timeframe.

• Asia Pacific is experiencing a sharp rise in obesity and overweight populations due to urbanization, changing dietary patterns, and reduced physical activity. Increasing consumption of processed foods and sedentary work environments are major contributing factors. Countries such as China, India, and Australia are witnessing growing health concerns related to obesity. As awareness of obesity-related complications grows, more individuals are seeking medical weight-loss solutions like intragastric balloons.
• The rapidly expanding middle-class population in countries such as China, India, and Southeast Asian nations is increasing demand for elective healthcare services. Individuals with higher disposable incomes are more willing to invest in weight-loss procedures and lifestyle treatments. Intragastric balloons are increasingly being marketed as a convenient and effective option for medical weight management. Rising healthcare spending is therefore contributing significantly to market expansion.

Latin America Intragastric Balloon Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• Latin America has experienced a significant rise in obesity rates over the past decade. Lifestyle changes, including reduced physical activity and increased consumption of processed foods, have contributed to this trend. Countries such as Brazil and Mexico are among the most affected. As obesity becomes a major public health concern, healthcare providers are promoting medical weight management solutions, including intragastric balloon therapy.
• In addition to medical necessity, weight-loss procedures in Latin America are also driven by aesthetic and lifestyle considerations. A growing number of individuals seek medical interventions to achieve desired body weight and improve overall appearance. Intragastric balloons offer a less invasive alternative to surgery while delivering visible results. This cultural emphasis on wellness and physical appearance is supporting market expansion.

Middle East and Africa Intragastric Balloon Market

The Middle East and Africa market is experiencing robust growth over the analysis timeframe.

• Many Middle Eastern countries are investing heavily in modernizing their healthcare systems. New hospitals, specialty clinics, and advanced medical centers are being developed to expand access to healthcare services. These facilities are equipped with advanced endoscopy units capable of performing intragastric balloon procedures. Improved healthcare infrastructure is therefore supporting market growth in the region.
• Public health campaigns and physician-led initiatives are improving awareness about the health consequences of obesity across the region. Governments are encouraging early diagnosis and treatment to reduce the prevalence of diabetes and cardiovascular diseases. As awareness increases, more individuals are exploring medical weight management options. This growing awareness is driving demand for intragastric balloon therapy in MEA.

Intragastric Balloon Market Share

The global intragastric balloon industry is moderately consolidated, with a mix of established medical device manufacturers and specialized bariatric device developers competing through product innovation, clinical efficacy, and global distribution networks. Companies are increasingly focusing on developing advanced balloon systems that offer improved safety, ease of placement, and enhanced patient comfort.

Continuous research and development activities, along with strategic partnerships with bariatric clinics and gastroenterology centers, are helping companies expand their market presence and strengthen their product portfolios. Key players include Boston Scientific, Allurion, Helioscopie, ReShape Lifesciences, and SPATZ, collectively accounting for ~67% of the total market share. These companies leverage strong brand recognition, regulatory approvals, and established clinical data to maintain their competitive advantage.

In addition to product innovation, market participants are increasingly adopting strategies such as geographic expansion, physician training programs, and collaborations with weight management clinics to improve product adoption. Several companies are also investing in swallowable and procedure-free balloon technologies that reduce the need for endoscopic placement and anesthesia.

The growing integration of digital health platforms and structured weight-loss programs alongside balloon therapy is further differentiating market offerings. As demand for minimally invasive obesity treatments continues to rise, competitive intensity in the intragastric balloon industry is expected to increase with the entry of new technologies and emerging regional players.

Intragastric Balloon Market Companies

A few of the prominent players operating in the intragastric balloon industry include:

• Allurion
• Beijing ZKSK Technology
• Boston Scientific
• Districlass Medical
• Endalis
• HEALTH WARE
• Helioscopie
• Medicone
• Medispar
• ReShape Lifesciences
• SHENYUN
• SILIMED
• SPATZ
• Suzhou Shenyun Medical
• Boston Scientific offers the Orbera intragastric balloon system, backed by over 20 years of clinical data and extensive global adoption across more than 80 countries. Its strong global distribution network and large clinical evidence base strengthen physician trust and market leadership.
• Allurion differentiates itself with the Elipse swallowable balloon, which does not require endoscopy, surgery, or anesthesia, making the procedure faster and more patient-friendly. The balloon is swallowed as a capsule and naturally passes after treatment, reducing procedural complexity and downtime.
• Helioscopie is known for the Heliosphere air-filled intragastric balloon, which is significantly lighter than liquid-filled balloons and designed to improve patient comfort. Its air-inflated design helps reduce common side effects such as nausea and vomiting during treatment.

The intragastric balloon market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Single intragastric balloon
• Dual intragastric balloon
• Triple intragastric balloon

Market, By Filling Material

• Saline-filled balloon
• Gas-filled balloon

Market, By Administration

• Endoscopy
• Pill form

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE